IRCCS Ospedale Galeazzi- Sant’Ambrogio, milan, Italy
IRCCS Ospedale Galeazzi- Sant’Ambrogio, milan, Italy
Reserve Amount: USD 100 . Pay total amount USD 2372 at the hospital.
Note: USD 100 reservation fee is non-refundable.
You Save : USD 474
The Whole-Body PET Scan with PSMA-F18 is a highly advanced, targeted diagnostic imaging procedure used primarily to detect, stage, and monitor prostate cancer. This scan uses the Prostate-Specific Membrane Antigen (PSMA) F-18 radiotracer, which binds specifically to PSMA receptors abundantly expressed on prostate cancer cells, including small or early metastatic deposits.
Compared with traditional imaging and other PET tracers, PSMA-F18 offers superior resolution, greater stability, and improved detection of small lesions, particularly in lymph nodes, bones, and soft tissues. It delivers clearer, sharper images and is especially valuable for identifying disease recurrence when PSA levels begin to rise after treatment.
This comprehensive diagnostic package includes whole-body PET/CT imaging, precise radiotracer injection, and expert evaluation by a nuclear medicine specialist. By accurately mapping active prostate cancer cells throughout the body, the PSMA-F18 PET scan plays a crucial role in guiding treatment planning, assessing therapy response, and enabling timely clinical decisions to improve patient outcomes.
Days in Hospital
0
Days in Hotel
0
Room Type
It is an advanced molecular imaging test that uses a PSMA-F18 radiotracer to detect prostate cancer cells throughout the body. The tracer binds specifically to PSMA receptors, making cancerous lesions obvious on PET/CT imaging.
PSMA-F18 has a strong affinity for prostate cancer cells and provides higher image clarity and stability than other PSMA tracers. It can detect very small or early metastatic deposits that may be missed on conventional imaging.
Doctors recommend it for initial staging of prostate cancer, evaluating suspected recurrence when PSA levels rise, monitoring metastatic disease, and guiding treatment decisions such as targeted therapy or radioligand therapy.
It helps identify cancer spread to lymph nodes, bones, and distant organs. It also detects micrometastatic disease, active tumor sites, and residual or recurrent cancer after surgery, radiotherapy, or hormonal treatment.
The radiotracer is administered by intravenous injection. After a short uptake period, the patient undergoes whole-body PET/CT imaging.
The entire procedure typically takes 1.5 to 2 hours, including tracer uptake time and imaging.
Yes. PSMA-F18 PET scans use a low dose of radioactive material that leaves the body naturally within hours. Side effects are infrequent.
Yes. PSMA-F18 PET imaging is highly sensitive, even at low PSA levels, making it one of the most reliable tools for early recurrence detection.
In most cases, no fasting or special preparation is required. Patients should follow any specific instructions provided by the imaging centre.
The scan provides precise information about cancer location and extent, helping oncologists tailor treatment strategies such as surgery, radiotherapy, systemic therapy, or PSMA-targeted radioligand therapy.
The Whole-Body PET Scan With PSMA-F18 Package is priced at approximately USD 2372 at IRCCS Ospedale Galeazzi- Sant’Ambrogio, offering a complete set of evaluations designed for early detection and cancer prevention.
To reserve the discounted Whole-Body PET Scan With PSMA-F18 Package, an advance payment of USD 100 is needed. The remaining balance can be paid directly at the hospital once your screening is completed.
The Whole-Body PET Scan With PSMA-F18 Package includes several value-added services such as expert consultation, priority scheduling, comprehensive clinical review, and round-the-clock support from a MediGence case manager to ensure a smooth and reassuring screening experience.
You may choose from various payment options, including cash, cheques, debit cards, credit cards, mobile payment platforms, and electronic bank transfers.
Yes, cancellation is allowed. Once processed, your refund will be credited back to your account within seven working days. Please note that the reservation fee is non-refundable.
Yes, modifications can be made depending on your specific needs and any additional screening requirements you may have.
After booking the Whole-Body PET Scan With PSMA-F18 Package, a dedicated case manager will be assigned to you, and you will receive an email confirmation. Your case manager will then assist you in coordinating the next steps to ensure a smooth process.
Yes, visa assistance is offered to support your medical travel. Our team helps with documentation, appointment letters, and other requirements to make the process easy and stress-free.
Every patient deserves access to the best possible treatment, guided by trust, transparency, and care. At MediGence, we are transforming how patients experience international healthcare by bringing the world’s best hospitals, doctors, and treatments within your reach, starting with a simple $100 reservation.
For years, patients seeking international treatment faced uncertainty, unclear pricing, long waiting times, and limited access to trusted hospitals. We changed that. With MediGence, you can now reserve your treatment package with just $100, securing your care, your price, and your confidence, all before you travel. This small step ensures you are always in control of your treatment journey, with no hidden costs or last-minute surprises.
Cancellation Policy
Exclusions
Disclaimer
